ReviewClinical Medicine Insights. Cardiology2025

A Real-World Retrospective Analysis of Secondary Prevention Patients Treated with Inclisiran over 27 Months.

Carl Deaney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.